3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
31
Phase 1
8
Phase 1/2
7
Phase 3
5
Phase 4
2
Phase EARLY_PHASE1
1
Phase 2/3
1
Status
Recruiting
2
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Kidney Neoplasms
2
Carcinoma, Renal Cell
2
Neoplasm Metastasis
1
Interventions
Propofol
9
Sevoflurane
7
Rituximab
7
Specimen Handling
6
Magnetic Resonance Spectroscopy
6
Dexamethasone
6
Trastuzumab
5
Enoxaparin
5
Bevacizumab
5
Nivolumab
4
Carboplatin
4
Capecitabine
4
Bupivacaine
4
trametinib
3
pirtobrutinib
3
pembrolizumab
3
dabrafenib
3
atezolizumab
3
apixaban
3
Lenalidomide
3
Indocyanine Green
3
Gemcitabine
3
Docetaxel
3
Cyclophosphamide
3
zanubrutinib
2
venetoclax
2
trastuzumab deruxtecan
2
ribociclib
2
polyethylene glycol 3350
2
pertuzumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Recruiting
×
cabozantinib
×
Clear all
NCT07028125
2025-10-07
CANIQOL
Centre Francois Baclesse
Phase 4
Recruiting
83 enrolled
NCT06934057
2025-09-24
CABOLD
Gustave Roussy, Cancer Campus, Grand Paris
Phase 4
Recruiting
50 enrolled